These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19331271)

  • 21. [Usefulness of botulinum toxin in gastrointestinal disorders].
    Zepeda-Gómez S; Valdovinos-Díaz MA
    Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment.
    Schulte-Baukloh H; Zurawski TH; Knispel HH; Miller K; Haferkamp A; Dolly JO
    BJU Int; 2007 Nov; 100(5):1075-80. PubMed ID: 17784887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.
    Hoebeke P; De Caestecker K; Vande Walle J; Dehoorne J; Raes A; Verleyen P; Van Laecke E
    J Urol; 2006 Jul; 176(1):328-30; discussion 330-1. PubMed ID: 16753434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of neurogenic bladder in children].
    Aubert D
    Prog Urol; 2008 Mar; 18(3):172. PubMed ID: 18472071
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of tension-type headache with botox: a review of the literature.
    Rozen D; Sharma J
    Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of Botox to treat glabellar rhytids.
    Bassichis BA; Thomas JR
    Facial Plast Surg Clin North Am; 2005 Feb; 13(1):11-4. PubMed ID: 15519924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
    Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
    Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics.
    Kuo HC
    Urology; 2005 Jul; 66(1):94-8. PubMed ID: 15992869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    Schmid DM; Roy S; Sulser T; Scheiner D
    BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonneurogenic voiding disorders: what's new?
    Glassberg KI; Combs AJ
    Curr Opin Urol; 2009 Jul; 19(4):412-8. PubMed ID: 19451817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
    Schulte-Baukloh H; Knispel HH; Stolze T; Weiss C; Michael T; Miller K
    Urology; 2005 Oct; 66(4):865-70; discussion 870. PubMed ID: 16230156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 36. Botox: not just for faces. It's making headlines for smoothing frown lines, but Botox can also ease some hard-to-treat medical conditions.
    Harv Womens Health Watch; 2003 Sep; 11(1):6-7. PubMed ID: 14505954
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
    BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botox therapy for refractory chronic migraine.
    Conway S; Delplanche C; Crowder J; Rothrock J
    Headache; 2005 Apr; 45(4):355-7. PubMed ID: 15836573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic and clinical aspects of BOTOX.
    Brin MF
    Toxicon; 2009 Oct; 54(5):676-82. PubMed ID: 19341758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.